1. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation;Bartholomew;Lancet,1997
2. Lamivudine resistance in immunocompetent chronic hepatitis B: incidence and patterns;Honkoop;J Hepatol,1997
3. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine therapy;Niesters;J Infect Dis,1998
4. The sequential occurrence of viral mutations in a liver transplant recipient reinfected with hepatitis B: hepatitis B immune globulin escape famciclovir non-response, followed by lamivudine resistance in graft loss;Man RA;J Hepatol,1998
5. Lamivudine (100 mg od) for 1 year significantly improves necro-inflammatory activity and reduces progression in fibrosis stage: results of a placebo-controlled multicentre study in Asia of lamivudine for chronic hepatitis B infection [abstract];Leung;Hepatology,1997